There have been six reported cases of a rare and severe blood clot in over 6.8 million J&J COVID-19 vaccine recipients
By Alexandria Hein
The CDC and FDA will pause the use of the Johnson & Johnson COVID-19 vaccine at federal sites after several instances of severe blood clots in recipients.
The Food and Drug Administration (FDA) together with the Centers for Disease Control and Prevention (CDC) is recommending a pause in the rollout of the Johnson & Johnson COVID-19 vaccine after several instances of severe blood clots in recipients.
According to the FDA, there have been six reported cases of the rare and severe type of blood clot in over 6.8 million Johnson & Johnson COVID-19 vaccine recipients.
Click the link below to read the rest of this story.
Click here to get more news from the Bulldog
On the go, but don’t want to miss any Bulldog news? Go to the App Store and download apps for Bulldog Reports and The Bulldog Show to your Apple and Android mobile devices. It’s free!